@lag Both my first oncologist and my family doctor also have patients who've lived with stage-4 prostate cancer for well over a decade (that's about how the long new treatments have been available — Zytiga (Abiraterone) became available in 2011, and Xtandi (Enzalutamide) in 2012 — so we don't know how much longer they'll last; possibly until they die of old age).